Dermatology and Therapy 9/2022

Open Access 29.07.2022 | Review

Update on Melasma—Part I: Pathogenesis

Ana Cláudia C. Espósito, Daniel P. Cassiano, Carolina N. da Silva, Paula B. Lima, Joana A. F. Dias, Karime Hassun, Ediléia Bagatin, Luciane D. B. Miot, Hélio Amante Miot

PDF-Version jetzt herunterladen Zum Volltext

Open Access 29.07.2022 | Review

Update on Melasma—Part II: Treatment

Daniel P. Cassiano, Ana Cláudia C. Espósito, Carolina N. da Silva, Paula B. Lima, Joana A. F. Dias, Karime Hassun, Luciane D. B. Miot, Hélio A. Miot, Ediléia Bagatin

PDF-Version jetzt herunterladen Zum Volltext

Open Access 26.08.2022 | Review

A Review of Phase 3 Trials of Dupilumab for the Treatment of Atopic Dermatitis in Adults, Adolescents, and Children Aged 6 and Up

Jennifer Cather, Melodie Young, Douglas C. DiRuggiero, Susan Tofte, Linda Williams, Tayler Gonzalez

PDF-Version jetzt herunterladen Zum Volltext

Open Access 20.08.2022 | Review

Prurigo Nodularis: A Review of IL-31RA Blockade and Other Potential Treatments

Anthony Bewley, Bernard Homey, Andrew Pink

PDF-Version jetzt herunterladen Zum Volltext

Open Access 30.07.2022 | Original Research

Randomized Clinical Trial of Conventional versus Indoor Daylight Photodynamic Therapy for Treatment of Actinic Cheilitis

Mariachiara Arisi, Benedetta Galli, Edoardo Guasco Pisani, Giuseppe La Rosa, Gaetano Licata, Sara Rovaris, Cesare Tomasi, Mariateresa Rossi, Marina Venturini, Luigi Spiazzi, PierGiacomo Calzavara-Pinton

PDF-Version jetzt herunterladen Zum Volltext

Open Access 02.08.2022 | Original Research

Risankizumab for the Treatment of Moderate to Severe Plaque Psoriasis in the Russian Federation

Liudmila Odnopozova, Anton Edin, Alexey Sukharev, Tianshuang Wu, Kerstin Aydin, Maureen Kelly, Alkes Khotko

PDF-Version jetzt herunterladen Zum Volltext

Open Access 07.08.2022 | Original Research

Durability of Response to Abrocitinib in Patients with Moderate-to-Severe Atopic Dermatitis After Treatment Discontinuation in a Phase 2b Trial

Melinda J. Gooderham, Giampiero Girolomoni, Julian O. Moore, Jonathan I. Silverberg, Robert Bissonnette, Seth Forman, Elena Peeva, Pinaki Biswas, Hernan Valdez, Gary Chan

PDF-Version jetzt herunterladen Zum Volltext

Open Access 10.08.2022 | Original Research

Treatment Patterns for Targeted Therapies, Non-Targeted Therapies, and Drug Holidays in Patients with Psoriasis

April Armstrong, Qian Xia, Anand Rojer John, Vardhaman Patel, Lauren Seigel

PDF-Version jetzt herunterladen Zum Volltext

Open Access 11.08.2022 | Original Research

Efficacy, Safety, and Pharmacoeconomic Analysis of Adalimumab and Secukinumab for Moderate-to-Severe Plaque Psoriasis: A Single-Center, Real-World Study

Gaojie Li, Yuanxia Gu, Qin Zou, Yiyi Wang, Yue Xiao, Dengmei Xia, Tongying Zhan, Xingli Zhou, Qian Wang, Wei Yan, Wei Li

PDF-Version jetzt herunterladen Zum Volltext

Open Access 22.08.2022 | Original Research

Chronic Cutaneous Lupus Erythematosus in a White Population: Dermoscopic Characteristics by Clinical Subtype, Lesion Location and Disease Duration

Magdalena Żychowska, Adam Reich

PDF-Version jetzt herunterladen Zum Volltext

Open Access 19.08.2022 | Original Research

High Tolerability, Favorable Safety, and Subjects' Preference for a Single 200 mg/2 mL Tildrakizumab Injection: A Phase I, Open-Label, Randomized Crossover Trial in Healthy Volunteers

Georgios Kokolakis, German Kreis, Meritxell Falqués, Mònica Aparici, Wiebke Sondermann

PDF-Version jetzt herunterladen Zum Volltext

Open Access 19.08.2022 | Original Research

Dupilumab Treatment of Atopic Dermatitis in Routine Clinical Care: Baseline Characteristics of Patients in the PROLEAD Prospective, Observational Study

Diamant Thaçi, Andrea Bauer, Ralph von Kiedrowski, Florian Schenck, Konstantin Ertner, Sophie Möller, Anja Fait, Mike Bastian, Matthias Augustin

PDF-Version jetzt herunterladen Zum Volltext

Open Access 26.08.2022 | Original Research

Pretreatment with an Aerosol Foam Containing Calcipotriene and Betamethasone Strongly Improves the Efficacy of Narrow-Band UVB Phototherapy

Gaetano Licata, Mariachiara Arisi, Marina Venturini, Mariateresa Rossi, Cesare Tomasi, Irene Calzavara-Pinton, Piergiacomo Calzavara-Pinton

PDF-Version jetzt herunterladen Zum Volltext

Open Access 28.07.2022 | Brief Report

Reassurance Techniques Do Not Significantly Impact Confidence in Biosimilars for Psoriasis: A Survey of a Convenience Sample of Individuals with Self-Identified Psoriasis

Matthew L. Hrin, Jeremy K. Bray, Steven R. Feldman

PDF-Version jetzt herunterladen Zum Volltext

Open Access 20.08.2022 | Case Series

Efficacy of Calcipotriol/Betamethasone Dipropionate Fixed-Combination Aerosol Foam in the Treatment of Localized Scalp Psoriasis: A Real-Life Case Series from Switzerland

Antonia Régnier, Ralph M. Trüeb

PDF-Version jetzt herunterladen Zum Volltext

Open Access 22.08.2022 | Case Series

Trifarotene 0.005% Cream in the Treatment of Facial and Truncal Acne Vulgaris in Patients with Skin of Color: a Case Series

James Q. Del Rosso, Edward Lain, Jean Philippe York, Andrew Alexis

PDF-Version jetzt herunterladen Zum Volltext

Springer Medizin

Dermatology and Therapy

Ausgabe 9/2022

Inhaltsverzeichnis (16 Artikel)

Update on Melasma—Part I: Pathogenesis

Update on Melasma—Part II: Treatment

A Review of Phase 3 Trials of Dupilumab for the Treatment of Atopic Dermatitis in Adults, Adolescents, and Children Aged 6 and Up

Prurigo Nodularis: A Review of IL-31RA Blockade and Other Potential Treatments

Randomized Clinical Trial of Conventional versus Indoor Daylight Photodynamic Therapy for Treatment of Actinic Cheilitis

Risankizumab for the Treatment of Moderate to Severe Plaque Psoriasis in the Russian Federation

Durability of Response to Abrocitinib in Patients with Moderate-to-Severe Atopic Dermatitis After Treatment Discontinuation in a Phase 2b Trial

Treatment Patterns for Targeted Therapies, Non-Targeted Therapies, and Drug Holidays in Patients with Psoriasis

Efficacy, Safety, and Pharmacoeconomic Analysis of Adalimumab and Secukinumab for Moderate-to-Severe Plaque Psoriasis: A Single-Center, Real-World Study

Chronic Cutaneous Lupus Erythematosus in a White Population: Dermoscopic Characteristics by Clinical Subtype, Lesion Location and Disease Duration

High Tolerability, Favorable Safety, and Subjects' Preference for a Single 200 mg/2 mL Tildrakizumab Injection: A Phase I, Open-Label, Randomized Crossover Trial in Healthy Volunteers

Dupilumab Treatment of Atopic Dermatitis in Routine Clinical Care: Baseline Characteristics of Patients in the PROLEAD Prospective, Observational Study

Pretreatment with an Aerosol Foam Containing Calcipotriene and Betamethasone Strongly Improves the Efficacy of Narrow-Band UVB Phototherapy

Reassurance Techniques Do Not Significantly Impact Confidence in Biosimilars for Psoriasis: A Survey of a Convenience Sample of Individuals with Self-Identified Psoriasis

Efficacy of Calcipotriol/Betamethasone Dipropionate Fixed-Combination Aerosol Foam in the Treatment of Localized Scalp Psoriasis: A Real-Life Case Series from Switzerland

Trifarotene 0.005% Cream in the Treatment of Facial and Truncal Acne Vulgaris in Patients with Skin of Color: a Case Series

Aktuelle Ausgaben

Ausgabe 1/2023

Ausgabe 12/2022

Ausgabe 11/2022

Ausgabe 10/2022

Ausgabe 9/2022

Ausgabe 8/2022

Ausgabe 7/2022

Ausgabe 6/2022

Ausgabe 5/2022

Ausgabe 4/2022

Neu im Fachgebiet Innere Medizin

Hilfe übers Bronchoskop bei COPD – neue Verfahren im Überblick

Nach ICI-Therapie: Wie häufig ist Diabetes?

UFOs sind weitgehend harmlos, versichert Studie

Vorteile für präoperative Chemotherapie bei Kolon-Ca.

Update Innere Medizin

Update Innere Medizin